₹ 20.37
0.27 (1.34%)
S
Syncom Formulations
₹ 20.37
Syncom Formulations EPS Summary (consolidated)
The latest quarterly EPS of Syncom Formulations as of Q1 Jun 2026 stands at ₹0.26. This is a 3.70% fall quarter on quarter and 23.81% growth same quarter last year. For the FY2026 the EPS of Syncom Formulations stands at ₹0.81. This is a 52.83% growth compared with FY2025.
Syncom Formulations EPS
EPS by Peers

S
Sun Pharmaceutical

D
Divis Laboratories

T
Torrent Pharmaceuticals

L
Laurus Labs

Z
Zydus Life Science
*Based on consolidated figures.

Pay Zero Brokerage on Delivery
Open FREE Demat Account
+91
Or Scan the QR Code to download the Dhan App

